African Americans may differ in their reasons for declining hepatitis C therapy compared to non-African Americans.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

8 citing papers in PubMed.

1. Factors influencing treatment outcome in hepatitis C virus minority patients at an inner-city hospital: A STROBE-complaint article.Medicine · 2020
   Observational
2. Racial/Ethnic and Socioeconomic Disparities in Use of Direct-Acting Antivirals Among Medicare Beneficiaries with Chronic Hepatitis C, 2014-2016.Journal of managed care & specialty pharmacy · 2019
   Article
3. Race, Age, and Geography Impact Hepatitis C Genotype Distribution in the United States.Journal of clinical gastroenterology · 2019
   Observational
4. Estimates of state-level chronic hepatitis C virus infection, stratified by race and sex, United States, 2010.BMC infectious diseases · 2018
   Article
5. Changing trends in complications of chronic hepatitis C.Liver international : official journal of the International Association for the Study of the Liver · 2018
   Observational
6. Racial-Ethnic Disparities in Uptake of New Hepatitis C Drugs in Medicare.Journal of racial and ethnic health disparities · 2017
   Article
7. Hepatitis C testing, infection, and linkage to care among racial and ethnic minorities in the United States, 2009-2010.American journal of public health · 2013
   Article
8. Reasons for HCV non-treatment in underserved African Americans: implications for treatment with new therapeutics.Annals of hepatology
   Article

Corrections and comments

• Comment on
  Reasons why patients infected with chronic hepatitis C virus choose to defer treatment: do they alter their decision with time?2007

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as